Out of posts on Ihub, but another good Seeking Alpha

New Post Public Reply Private Reply Replies (1) Message Board
ericseb2003
Out of posts on Ihub, but another good Seeking Alpha article today on Biotech Correction seeming to be over (technically).


Optioins2Wealth new Seeking Alpha article - The Biotech Correction Is Finally Over!

Similar to an Oppenheimer call on CNBC the other day

http://seekingalpha.com/instablog/6566781-opt...on-finally

The Biotech Correction Is Finally Over!
Mar 31, 2016 2:57 AM | about stocks: IBB, ACAD, NVIV, PETX, XON, ZIOP


On Monday, July 20th, 2015, the IBB Index, which is the most followed proxy for the Biotech sector, hit an intraday high of 400.79 and 204 days later on Tuesday, Feb 9th, 2016, it notched an intraday low of 240.03, a 40% correction in less thn 7 months!

The drop was anything but gradual...

Two weeks after scoring its all-time high, the index dropped below its 50 day moving average (DMA) line support and then after another 2 weeks, it dropped below its 200 DMA line...The index made a couple of feeble attempts to regain those important support levels but failed to hold, and pretty much had been in a free-fall until it hit the intraday low of 240...

Since printing that low, the index has basically been in a consolidation mode, with the price always being significantly below its 50 DMA, which incidentally, is now its first major resistance...Only after the price of the index closes above this important moving average line for 2 consecutive days, will most market technicians feel safe enough to bet on the long side...

Today, March 30h, 2016, about 8 months after scoring its intraday high and after more than 2 months of relatively tight consolidation phase, the index, imho, gave a clear technical BUY signal...The IBB index, intraday, pierced through its 50 DMA from below, before pulling back to close down for the day...Also in the process, on its PnF chart, the index switched back into Xs and made a double-top @ 260...

(click to enlarge)

(click to enlarge)

I therefore strongly believe that the correction in the Biotech sector is technically now over and a new uptrend has begun...A close above 262 on its candlestick chart and a print of 264 on IBB's PnF chart, which will be the break of the double-top, will further confirm my hypothesis...

I expect the market to most probably flash both the confirmatory signals in the next 2 days...

But certainly by next week...

Giddy Up!

karim

DISCLAIMER: All postings made here are strictly for my personal record keeping and in no way, shape or form, am I even remotely suggesting others to follow my Buy and Sell moves. Trading options is definitely not for the faint of heart as one's portfolio can move up, or down, anywhere between 10%-30% during a single trading day. Feel free to follow my progress here, but PLEASE do not follow my moves. However, if, in spite of all my exhortations, should you decide to do so, be advised that you, and ONLY YOU will be responsible for any losses that you may suffer...In other words, the onus is strictly on you. On the other hand, if the move(s) result in a profit for you, I am open to discussing a split.

Disclosure: I am/we are long IBB, ADXS, PETX, XON, ZIOP.
Stocks: IBB, ACAD, NVIV, PETX, XON, ZIOP

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 115

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 163

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 104

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 98

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 89

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

SPHEREboard 6.11 Launch Enhances Identity Security Solutions

Updated Category News Views 153

SPHEREboard 6.11 Launch Elevates Identity Intelligence SPHERE, a frontrunner in Identity Intelligence, has recently accomplished two major milestones that are set to reshape identity security: the launch of SPHEREboard 6.11 and the formation of a dedicated Board of Advisors. These initiatives reflect SPHERE's unwavering commitment to not only enhancing identity hygiene...

Continue Reading
Edible Garden Expands Organic Herb Offerings in New Jersey

Updated Category News Views 127

Edible Garden Launches Organic Herb Line in Local Supermarkets Exciting news for herb enthusiasts! Edible Garden AG Incorporated, a leader in controlled environment agriculture, has announced the launch of its USDA Organic herb product line at select supermarkets in New Jersey. These include Superfresh, City Supermarket, and Fine Fare Supermarkets. Distinct Offerings from...

Continue Reading
Strengthening Cybersecurity: The Evolving Role of CISOs

Updated Category News Views 48

Cybersecurity in Today's Business Landscape As organizations navigate through the constantly changing threat landscape, cybersecurity has emerged as a crucial element of strategic business frameworks. Companies are increasingly recognizing the significance of enhancing their security postures, prioritizing the role of Chief Information Security Officers (CISOs), and...

Continue Reading
Qnity Takes Major Steps With Form 10 Registration Announcement

Updated Category News Views 232

Qnity Celebrates Effective Form 10 Registration Statement In a recent development that emphasizes growth, Qnity is thrilled to announce the effectiveness of its Form 10 registration statement. This milestone is crucial for Qnity as it advances its strategies while aligning with DuPont de Nemours, Inc. (NYSE: DD). The registration is a significant step towards enhancing...

Continue Reading
Important Position Disclosure by Rathbones Group Plc

Updated Category News Views 119

Overview of the Disclosure Process Understanding the dynamics of stock market dealings is crucial for every investor. Rathbones Group Plc plays a significant role in this context, especially when it comes to complying with regulatory frameworks. One such requirement is the public disclosure related to significant ownership positions in relevant securities, particularly...

Continue Reading